Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis. Multicenter Prospective

NCT02338427 is registered in ClinicalTrials.gov with Centre Hospitalier Departemental Vendee as lead sponsor.

NCT NCT02338427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02338427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis. Multicenter Prospective
Lead sponsor
Centre Hospitalier Departemental Vendee
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2016
Completion date
November 30, 2018
Enrollment
140 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis